Starna offers new photometric linearity reference sets

Published: 13-May-2010

Suitable for pharmaceutical QA laboratories

Starna offers new photometric linearity reference sets
Starna Scientific’s near infrared (NIR) traceable photometric linearity reference sets are now available for pharmaceutical QA labs and customer support organisations seeking to qualify their NIR systems. These reference sets offer Operational Qualification (OQ) and Performance Qualification (PQ) of the transmittance scale in the NIR using industry standard protocols.

The sets are based on easy to handle, non-consumable Certified Reference Materials for qualifying the NIR Transmittance scale. The wavelength range covered is 1100 to 2850nm, with a %T (A) range of 1.5 %T (1.82A) to 61%T (0.21A).

Starna, based in Hainault, Essex, UK, has many years of experience gained preparing Visible Neutral Density filter references for ISO 17025 and ISO Guide 34 accreditation and produces references for National Measurement Institutions (NMIs).

See more

You may also like

Manufacturing
The 7 most common process development mistakes

The 7 most common process development mistakes

Read more
At laboratory scale, processes may appear predictable, repeatable, and well understood. However this perceived level of control can be misleading

Trending Articles

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Manufacturing
The 7 most common process development mistakes

The 7 most common process development mistakes

At laboratory scale, processes may appear predictable, repeatable, and well understood. However this perceived level of control can be misleading
Manufacturing
What are injectable hydrogel microspheres?

What are injectable hydrogel microspheres?

The demand for longer-lasting therapies is accelerating innovation in injectable drug delivery, driven by the need to maintain stable therapeutic levels while minimising repeated administration
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
What Operation TrialBlazer means for CDMOs and CMC strategy

What Operation TrialBlazer means for CDMOs and CMC strategy

The FDA's new framework cuts Phase I data requirements, opens platform manufacturing data reuse and creates a new CRO/CDMO review role as HHS moves to close the gap with China's faster clinical trial pipeline — but how will this affect the pharma sector?
Digital
Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations

Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations

The digital data fabric links R&D, analytical development and GMP manufacturing, replacing periodic reporting with continuous audit-ready transparency aligned to FDA, EMA and PMDA expectations
Manufacturing
Piramal Pharma Solutions highlights strong performance across more than 200 customer audits

Piramal Pharma Solutions highlights strong performance across more than 200 customer audits

Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes
Packaging
SnapSlide and Paramount Global jointly awarded gold by National Association of Container Distributors

SnapSlide and Paramount Global jointly awarded gold by National Association of Container Distributors

Companies’ collaboration on new accessible dispensing system for medicine vials earns top honours in NACD Packaging Awards “Pharmaceutical and Nutraceutical" category
Regulatory
Pheno Therapeutics gains FDA IND clearance for first-in-class GPR17 antagonist PTD802 in MS

Pheno Therapeutics gains FDA IND clearance for first-in-class GPR17 antagonist PTD802 in MS

The clearance enables a first-in-human trial of the UCB-licensed remyelination candidate, marking the first GPR17 programme to reach clinical development for multiple sclerosis and related demyelinating diseases
Subscribe now